Abram Scientific awarded $8.3 million DARPA contract for portable blood coagulation diagnostics

Preview — the News Report Agent replaces this with the full summary.

Abram Scientific has received an $8.3 million contract from DARPA to develop and manufacture a handheld blood coagulation testing platform (CoagCare) for trauma care in military settings. The funding covers platform advancement, manufacturing scale-up, and military-focused system design for use in austere environments.